267 related articles for article (PubMed ID: 25824210)
1. Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation.
Kersemaekers WM; Dogterom P; Xu J; Marcantonio EE; de Greef R; Waskin H; van Iersel ML
Antimicrob Agents Chemother; 2015; 59(6):3385-9. PubMed ID: 25824210
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
3. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
Courtney R; Wexler D; Radwanski E; Lim J; Laughlin M
Br J Clin Pharmacol; 2004 Feb; 57(2):218-22. PubMed ID: 14748822
[TBL] [Abstract][Full Text] [Related]
4. Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.
Krishna G; Ma L; Martinho M; O'Mara E
Antimicrob Agents Chemother; 2012 Aug; 56(8):4196-201. PubMed ID: 22615291
[TBL] [Abstract][Full Text] [Related]
5. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
Lin TY; Yang MH; Chang FY
Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers.
Krishna G; Ma L; Martinho M; Preston RA; O'Mara E
J Antimicrob Chemother; 2012 Nov; 67(11):2725-30. PubMed ID: 22833639
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
Kendall J; Papich MG
Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-mass spectrometry method for the quantification of posaconazole in human plasma: application to pharmacokinetics following single-dose administration in the fasted state and with a high-fat meal.
Xu HR; Chu NN; Chen WL; Wang ZD; Li XN
Pharmazie; 2013 Mar; 68(3):173-7. PubMed ID: 23556334
[TBL] [Abstract][Full Text] [Related]
10. A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
van Iersel MLPS; Rossenu S; de Greef R; Waskin H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712663
[TBL] [Abstract][Full Text] [Related]
11. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
Krishna G; Sansone-Parsons A; Kantesaria B
Curr Med Res Opin; 2007 Jun; 23(6):1415-22. PubMed ID: 17559737
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.
Krishna G; Moton A; Ma L; Medlock MM; McLeod J
Antimicrob Agents Chemother; 2009 Mar; 53(3):958-66. PubMed ID: 19075045
[TBL] [Abstract][Full Text] [Related]
13. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
Cornely OA; Duarte RF; Haider S; Chandrasekar P; Helfgott D; Jiménez JL; Candoni A; Raad I; Laverdiere M; Langston A; Kartsonis N; Van Iersel M; Connelly N; Waskin H
J Antimicrob Chemother; 2016 Mar; 71(3):718-26. PubMed ID: 26612870
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension.
Durani U; Tosh PK; Barreto JN; Estes LL; Jannetto PJ; Tande AJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4914-8. PubMed ID: 26055378
[TBL] [Abstract][Full Text] [Related]
15. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.
Kraft WK; Chang PS; van Iersel ML; Waskin H; Krishna G; Kersemaekers WM
Antimicrob Agents Chemother; 2014 Jul; 58(7):4020-5. PubMed ID: 24798274
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pharmacokinetics of posaconazole and rifabutin following co-administration to healthy men.
Krishna G; Parsons A; Kantesaria B; Mant T
Curr Med Res Opin; 2007 Mar; 23(3):545-52. PubMed ID: 17355736
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment.
Moton A; Krishna G; Ma L; O'Mara E; Prasad P; McLeod J; Preston RA
Curr Med Res Opin; 2010 Jan; 26(1):1-7. PubMed ID: 19886860
[TBL] [Abstract][Full Text] [Related]
20. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]